CALC CalciMedica, Inc.

P/E --
Forward P/E --
Price/Sales --
Beta 1.106
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ CalciMedica is trading 5.8% down today as hotter September inflation lifted Treasury yields

CalciMedica is trading 5.8% down at $1.05, a move consistent with broader market pressure after hotter-than-expected September inflation lifted Treasury yields...

🟒 CalciMedica is trading 7.1% up with no clear company-specific catalyst identified

CalciMedica is trading up 7.14% at $1.20 as of 11:00 a.m. ET on October 14, 2026; no clear company-specific announcement explaining the gain was identified. -...

πŸ”΄ CalciMedica is trading 5.4% down with no identified company-specific catalyst

CalciMedica is trading 5.39% down at $1.14 on October 13, 2026, with no company-specific announcement or catalyst identified. - The company’s press-release...

🟒 CalciMedica is trading 7.1% up in pre-market

CalciMedica is trading at $1.29, up 7.10% in pre-market, with no clear company-specific catalyst identified. - The latest company press-release listing shows...

πŸ”΄ CalciMedica is trading 5.5% down with no clear company-specific catalyst

CalciMedica is trading 5.5% lower at $1.20, with no clear company-specific announcement explaining the decline. - Broad market indexes were mixed, rather than...

🟒 CalciMedica is trading 6.1% up in after-hours trading

CalciMedica is trading 6.11% higher at $1.39 in after-hours on October 8, with no company-specific announcement identified. - CalciMedica closed the regular...

πŸ”΄ CalciMedica is trading 10.67% down amid biotech and broader market weakness

CalciMedica is trading 10.67% down at $1.34, amid broader biotech and market weakness, with no verified company-specific announcement identified for October...

πŸ”΄ CalciMedica is trading 5.3% down today amid biotech-sector weakness

CalciMedica is trading 5.33% lower at $1.42, with broader biotech weakness the clearest contemporaneous context. - Biotech ETF XBI is down 2.04% during the...

πŸ”΄ CalciMedica is trading 6.5% down today with no clear company-specific catalyst

CalciMedica is trading 6.5% down at $1.44 on October 6, 2026, with no new company-specific announcement clearly explaining the decline. - A September 30...

🟒 CalciMedica is trading 5.56% up in pre-market; no clear catalyst identified

CalciMedica is trading 5.56% up in pre-market at $1.71 on October 5, with no clear company-specific catalyst identified. - The October 2 close was $1.60. - A...

πŸ”΄ CalciMedica is trading 6.17% down in pre-market with no clear company-specific catalyst identified

CalciMedica is trading at $1.52, down 6.17%, in pre-market, with no clear company-specific catalyst identified for the October 5 decline. β€’ The latest SEC...

🟒 CalciMedica is trading 10.4% up in pre-market with no clear catalyst identified

CalciMedica is trading 10.37% higher at $1.81 in pre-market on October 2, 2026; the cause remains uncertain. - Shares closed at $1.65 on October 1. - A...

🟒 CalciMedica is trading 9.8% up in after-hours trading with no clear catalyst identified

CalciMedica is trading at $1.80, up 9.76%, in after-hours trading with no verified October 1 announcement or clear catalyst identified. - A September 30...

🟒 CalciMedica is trading 5.43% up

CalciMedica is trading at $1.71, up 5.43%; no clear company-specific catalyst for the gain was found. - A September 30 prospectus supplement disclosed up to...

πŸ”΄ CalciMedica is trading 6.17% down in pre-market amid potential $25 million stock-sale filing

CalciMedica is trading 6.17% down at $1.52 in pre-market on October 1, amid a September 30 filing allowing up to $25 million in common-stock sales; whether it...

CalciMedica Files to Sell Up to $25M in Stock via At-The-Market Offering

CalciMedica Files to Sell Up to $25M in Stock via At-The-Market Offering

CalciMedica has filed a prospectus supplement related to the potential sale of its common stock, with an aggregate offering price of up to $25 million, through...

πŸ”΄ CalciMedica is trading 5.6% down

CalciMedica is trading 5.6% lower at $1.60; no clear company-specific catalyst for the September 29 move was identified. - The decline follows a 4.0% loss at...

πŸ”΄ CalciMedica is trading 5.7% down today with no identified company-specific catalyst

CalciMedica is trading 5.7% lower at $1.65, with no clear company-specific catalyst identified for the September 28 decline. - The company’s...

πŸ”΄ CalciMedica is trading 6.32% down today with no clear catalyst identified

CalciMedica is trading 6.32% lower at $1.63, down from its September 24 close of $1.74; no company-specific catalyst for the September 25 decline was...

🟒 CalciMedica is trading 6.67% up in after-hours trading

CalciMedica is trading at $1.92, up 6.67%, after hours; no confirmed company-specific catalyst for the move was identified. - It closed at $1.80 on September...